Crewe Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1
| Closed | -$178 | – | 421 |
|
|
2023
Q3 | $178 | Hold |
1
| – | – | ﹤0.01% | 453 |
|
|
2023
Q2 | $190 | Sell |
1
-26
| -96% | -$4.94K | ﹤0.01% | 723 |
|
|
2023
Q1 | $5.41K | Sell |
27
-23
| -46% | -$4.61K | ﹤0.01% | 626 |
|
|
2022
Q4 | $11.9K | Sell |
50
-36
| -42% | -$8.56K | ﹤0.01% | 522 |
|
|
2022
Q3 | $17K | Buy |
86
+15
| +21% | +$2.97K | ﹤0.01% | 498 |
|
|
2022
Q2 | $10K | Buy |
+71
| New | +$10K | ﹤0.01% | 587 |
|